Paul J Fitzgerald
Overview
Explore the profile of Paul J Fitzgerald including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wlaz P, Fitzgerald P, Zmudzki P, Socala K
Pharmacol Rep
. 2025 Mar;
PMID: 40069538
Background: A number of rodent studies have investigated the effects of alcohol (ethanol) administration on the catecholaminergic neurotransmitters, norepinephrine (NE) and dopamine (DA). These studies suggest that presentation of alcohol...
2.
Fitzgerald P
Clin Psychopharmacol Neurosci
. 2024 Jul;
22(3):405-415.
PMID: 39069680
Frontal alpha asymmetry (FAA) is an electroencephalography (EEG) measure that quantifies trait-like left versus right hemisphere lateralization in alpha power. Increased FAA indicates relatively greater left than right frontal cortex...
3.
Fitzgerald P
Neurosci Lett
. 2024 Mar;
827:137734.
PMID: 38499279
Identifying additional noninvasive biomarkers for affective disorders, such as unipolar major depressive disorder (MDD) and bipolar disorder (BD), could aid in the diagnosis and treatment of these prevalent and debilitating...
4.
Fitzgerald P
Epilepsy Res
. 2024 Jan;
200:107286.
PMID: 38217951
Angelman syndrome (AS) is a rare neurodevelopmental disorder that is typically caused by deletion or a loss-of-function mutation of the maternal copy of the ubiquitin ligase E3A (UBE3A) gene. The...
5.
Fitzgerald P
Molecules
. 2022 May;
27(9).
PMID: 35566075
Previous studies in animals and humans have shown multiple types of interaction between alcohol (ethanol) intake and the catecholamine signaling molecules: dopamine, norepinephrine and epinephrine. This literature suggests that the...
6.
7.
Fitzgerald P
Front Behav Neurosci
. 2021 Oct;
15:673634.
PMID: 34658805
Major depressive disorder (MDD) remains a significant public health problem worldwide, and revised treatment strategies are therefore urgently needed, including the creation of novel antidepressant compounds or using existing molecular...
8.
Fitzgerald P
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34639047
It is well established that a wide range of drugs of abuse acutely boost the signaling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis, where norepinephrine and epinephrine...
9.
Fitzgerald P
Int J Mol Sci
. 2021 Jul;
22(14).
PMID: 34298984
While much of biomedical research since the middle of the twentieth century has focused on molecular pathways inside the cell, there is increasing evidence that extracellular signaling pathways are also...
10.
Cerda I, Fitzgerald P
Psychiatry Res
. 2021 Jun;
303:114054.
PMID: 34153629
We present a neurochemical model of unipolar major depressive disorder that makes predictions for optimizing pharmacological treatment of this debilitating neuropsychiatric disorder. We suggest that there are two principal electrophysiological...